Back

Assessing the impact of transcatheter edge-to-edge repair on reverse remodeling in secondary mitral regurgitation: a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Transcatheter mitral interventions Mitral Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speakers

Photo
Doctor Adolf Lichtfusz

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

Photo
Doctor Judit Papp

Central Hospital Of Northern Pest Military Hospital, Budapest (Hungary)

4 More presentations in this session

Presentation thumbnail
Prognostic impact of mitral balloon valvuloplasty for mitral stenosis patients: when the right heart catheterization is the answer
Doctor F. Nascimento Ferreira (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic role of the COAPT risk score in patients with secondary mitral regurgitation (SMR) undergoing M-TEER: Results of a real world registry
Doctor G. Martino (Rende, IT)
Abstract Slides Video
Presentation thumbnail
Impact of conscious sedation or general anesthesia on mitral valve function after percutaneous edge-to-edge reconstruction: a single cohort study
Doctor A. Rroku (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Impact of leaflet coaptation gap on procedural and clinical outcomes after transcatheter edge-to-edge-repair for functional mitral regurgitation
Doctor N. Nishiura (Kurashiki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Transcatheter mitral interventions

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Predictors of left atrial remodelling after edge-to-edge transcatheter valve repair of atrial secondary mitral regurgitation
thumbnail
Congress Presentation
Transcatheter-edge-to-edge-repair of functional mitral regurgitation in advanced HFrEF: the impact of intrinsic left ventricular performance on the degree of MR reduction and clinical outcome
thumbnail
Congress Presentation
TEER plus medical therapy vs medical therapy alone for symptomatic moderate-to-severe functional mitral regurgitation: a comprehensive, up-to-date meta-analysis of randomized trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources